P99 Stock Overview
Provides Software-as-a-Service solutions to health professionals and partners in Norway and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
CodeLab Capital AS Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.096 |
| 52 Week High | kr0.12 |
| 52 Week Low | kr0.037 |
| Beta | 1.66 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 97.54% |
| 3 Year Change | -87.45% |
| 5 Year Change | n/a |
| Change since IPO | -87.29% |
Recent News & Updates
Recent updates
Shareholder Returns
| P99 | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | 0% | 3.8% | 1.6% |
| 1Y | 97.5% | -24.1% | 7.3% |
Return vs Industry: P99 exceeded the German Healthcare Services industry which returned -25% over the past year.
Return vs Market: P99 exceeded the German Market which returned 6.5% over the past year.
Price Volatility
| P99 volatility | |
|---|---|
| P99 Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 4.0% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.6% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: P99 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine P99's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 200 | Kristian Ikast | www.codelabcapital.com |
CodeLab Capital AS provides Software-as-a-Service solutions to health professionals and partners in Norway and internationally. It develops PatientSky cloud platform and related technology to provide patient care. The company was formerly known as PatientSky Group AS.
CodeLab Capital AS Fundamentals Summary
| P99 fundamental statistics | |
|---|---|
| Market cap | €9.94m |
| Earnings (TTM) | -€12.06m |
| Revenue (TTM) | €13.17m |
0.8x
P/S Ratio-0.8x
P/E RatioIs P99 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| P99 income statement (TTM) | |
|---|---|
| Revenue | kr152.90m |
| Cost of Revenue | kr156.93m |
| Gross Profit | -kr4.03m |
| Other Expenses | kr136.01m |
| Earnings | -kr140.05m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
May 31, 2024
| Earnings per share (EPS) | -0.69 |
| Gross Margin | -2.64% |
| Net Profit Margin | -91.60% |
| Debt/Equity Ratio | 0% |
How did P99 perform over the long term?
See historical performance and comparison